Annual ROE
140.89%
+707.75%+124.85%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual return on equity is 140.89%, with the most recent change of +707.75% (+124.85%) on December 31, 2021.
- During the last 3 years, PHAS annual ROE has risen by +187.71% (+400.92%).
Performance
PHAS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
113.27%
-60.14%-34.68%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly return on equity is 113.27%, with the most recent change of -60.14% (-34.68%) on June 30, 2022.
- Over the past year, PHAS quarterly ROE has dropped by -1298.19% (-91.97%).
Performance
PHAS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PHAS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +124.8% | -92.0% |
| 3 y3 years | +400.9% | +158.4% |
| 5 y5 years | +1239.3% | - |
PHAS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -66.7% | at low |
| 5 y | 5-year | at high | -502.3% | -92.0% | -826.7% |
| alltime | all time | at high | -502.3% | -99.1% | -826.7% |
PhaseBio Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | 113.27%(-34.7%) |
| Mar 2022 | - | 173.41%(-49.0%) |
| Dec 2021 | 140.89%(-124.9%) | 340.16%(-38.0%) |
| Sep 2021 | - | 548.52%(-61.1%) |
| Jun 2021 | - | 1411.46%(-271.5%) |
| Mar 2021 | - | -823.09%(+98.8%) |
| Dec 2020 | -566.86%(+700.9%) | -414.11%(+123.9%) |
| Sep 2020 | - | -184.92%(+64.4%) |
| Jun 2020 | - | -112.51%(+48.8%) |
| Mar 2020 | - | -75.59%(+18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -70.78%(+51.2%) | -63.84%(-48.9%) |
| Sep 2019 | - | -124.89%(-35.6%) |
| Jun 2019 | - | -193.86%(-101.5%) |
| Mar 2019 | - | 13.19 K%(+8175.3%) |
| Dec 2018 | -46.82%(-545.1%) | 159.35%(+377.1%) |
| Sep 2018 | - | 33.40%(-20.4%) |
| Jun 2018 | - | 41.97%(+330.5%) |
| Mar 2018 | - | 9.75%(+86.4%) |
| Dec 2017 | 10.52%(-0.6%) | 5.23% |
| Dec 2016 | 10.58% | - |
FAQ
- What is PhaseBio Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual ROE year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly ROE year-on-year change?
What is PhaseBio Pharmaceuticals annual return on equity?
The current annual ROE of PHAS is 140.89%
What is the all time high annual ROE for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual return on equity is 140.89%
What is PhaseBio Pharmaceuticals annual ROE year-on-year change?
Over the past year, PHAS annual return on equity has changed by +707.75% (+124.85%)
What is PhaseBio Pharmaceuticals quarterly return on equity?
The current quarterly ROE of PHAS is 113.27%
What is the all time high quarterly ROE for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly return on equity is 13.19 K%
What is PhaseBio Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, PHAS quarterly return on equity has changed by -1298.19% (-91.97%)